Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ERBC Group is an independent European contract research organization specializing in non-clinical/preclinical studies that bridge the gap between drug/product discovery and clinical trials. With headquarters in Baugy, France—and additional sites in Italy—the company offers comprehensive scientific services including toxicology/safety pharmacology/pharmacokinetics/bioanalytics using advanced animal models. Through strategic partnerships like that with Menarini Biotech/CDMO announced April 2025, ERBC delivers integrated solutions enabling efficient transition from research to First-In-Human trials for biopharma innovators worldwide. The company operates under strict GLP/GCP standards supporting regulatory compliance at every step.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ERBC.